The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
Sungkyunkwan University researchers in Korea ran a nationwide cohort analysis linking allergic diseases to increased optic neuritis risk, with allergic rhinitis showing the strongest association.